Company · CIK 0001933414 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Mineralys Therapeutics, Inc. · MLYS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 9:49 pm EDT | Brian Taylor SlingsbyDirector | 104,320 | $28.81 | $3,005,303 | 7,805,718 | −1.32% | |
| Sep 21, 2026 SForm 4 → | Sep 22, 6:48 pm EDT | Eric WarrenChief Commercial Officer | 7,438 | $28.12 | $209,136 | 38,400 | −16.2% | 10b5-1 |
| Sep 21, 2026 MForm 4 → | Sep 22, 6:48 pm EDT | Eric WarrenChief Commercial Officer | 7,438 | $13.24 | $98,479 | 45,838 | — | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 17, 5:41 pm EDT | Daphne KarydasDirector | 3,000 | $28.58 | $85,740 | 6,200 | −32.6% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 17, 5:41 pm EDT | Daphne KarydasDirector | 3,000 | $12.02 | $36,060 | 9,200 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 MForm 4 → | Sep 22, 6:48 pm EDT | Eric WarrenChief Commercial Officer | 7,438 | — | — | 230,563 | — | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 17, 5:41 pm EDT | Daphne KarydasDirector | 3,000 | — | — | 35,000 | — | 10b5-1 |